Algorithm-guided treatment versus treatment as usual for major depression: Regular Article

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 5, 2009, Pages 652-657

  Yoshino, Aihide ^a   Sawamura, Takehito ^a   Kobayashi, Nobuhisa ^a   Kurauchi, Sachi ^a   Matsumoto, Aki ^a   Nomura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Algorithm guided treatment; Clinical outcome; Lithium augmentation; Major depression; Treatment as usual

Indexed keywords

FLUVOXAMINE; IMIPRAMINE; LITHIUM; MILNACIPRAN; PAROXETINE;

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; REMISSION;

ALGORITHMS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 70349305458     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2009.02009.x     Document Type: Article

References (16)

1. Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: Are they effective and why? A systematic review. Biol. Psychiatry 2006 59 : 1029 1038.
2. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: Treating depression in the real world. Cleve. Clin. J. Med. 2008 75 : 57 66.
3. Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: A meta-analysis comparing within- versus across-class switches. Biol. Psychiatry 2008 63 : 699 704.
4. Quitkin FM, McGrath PJ, Stewart JW et al. Remission rates with 3 consecutive antidepressant trials: Effectiveness for depressed outpatients. J. Clin. Psychiatry 2005 66 : 670 676.
5. Crismon ML, Trivedi M, Pigott TA et al. The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder. J. Clin. Psychiatry 1999 60 : 142 156. (Pubitemid 29168686)
6. Adli M, Berghofer A, Linden M et al. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: Results of a 2-year observational algorithm study. J. Clin. Psychiatry 2002 63 : 782 790.
7. Bondolfi G, Aubry JM, Golaz J, Gex-Fabry M, Gervasoni N, Bertschy G. A stepwise drug treatment algorithm to obtain complete remission in depression: A Geneva study. Swiss Med. Wkly. 2006 136 : 78 85.
8. Trivedi MH, Rush AJ, Crismon ML et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch. Gen. Psychiatry 2004 61 : 669 680.
9. Motohashi N. Algorithm for the Treatment of Mood Disorder (in Japanese). Jiho, Tokyo, 2003.
10. Nomura S, Sawamura T, Kobayashi N, Yoshino A. Medication algorithm for mood disorders: Present status and future direction in Japan. Int. J. Psychiatry Clin. 2004 8 : 139 145.
11. Valenstein M, McCarthy JF, Austin KL, Greden JF, Young EA, Blow FC. What happened to lithium? Antidepressant augmentation in clinical settings. Am. J. Psychiatry 2006 163 : 1219 1225.
12. Nierenberg AA, Amsterdam JD. Treatment-resistant depression: Definition and treatment approaches. J. Clin. Psychiatry 1990 51 (Suppl. 39 47.
13. Dording CM. Antidepressant augmentation and combinations. Psychiatr. Clin. North Am. 2000 23 : 743 755.
14. Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: Two meta-analyses of randomized, placebo-controlled trials. J. Clin. Psychiatry 2007 68 : 935 940.
15. Guy W. Early Clinical Drug Evaluation (ECDEU) Assessment Manual. National Institute for Mental Health, Rockville, MD, 1976.
16. Bschor T, Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr. Pharm. Des. 2006 12 : 2985 2992.